110 Startups
  • Sector
  • Participated in
  • Year of participation

Avalanche Medical

  • 2018
  • Medical Device
  • Venture Challenge
Provide pain relief and functional restoration for patients suffering from focal knee cartilage defects, which is a chronic and severely disabling musculoskeletal condition.

Beephonix

  • 2022
  • Medical Device
  • Venture Challenge
Beephonix develops a biomimetic microphones to improve hearing in noisy conditions. The approach mimics the way bees move their antennae.

BI/OND

  • 2016
  • Enabling Technology
  • Venture Challenge
The hardware of choice for OCC in-vitro testing of drug candidates, reducing the incidence of false positives and false negative in pre-clinical trials.

BIMINI Biotech

  • 2019
  • Therapeutics
  • Venture Challenge
BIMINI Biotech is developing therapeutic strategies for major unmet medical needs. Our first development program targets the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases and ageing.

Biomimiq

  • Enabling Technology
  • Venture Challenge
Biomimiq provides both healthy and diseased in vitro human skin equivalent for animal free compound screening and safety testing services

Breathomix

  • 2015
  • Diagnostics
  • Venture Challenge
The goal of Breathomix is to bring exhaled breath based diagnosis to medicine in a point of care setting.

CC Diagnostics

  • 2017
  • Diagnostics
  • Venture Challenge
CC Diagnostics offers a superior, easily implementable triage test with an unsurpassed specificity and reproducibility, which will decrease the number of misdiagnosed women, decrease healthcare costs, and increase screening participation.

Cell4Pharma

  • 2011
  • Enabling Technology
  • Venture Challenge
ciPTEC is a human renal cell line that mimics the proximal tubule cells of the kidney. These cells are a main target for drug-induced kidney injury, caused by their role in highly efficient transport of drugs and toxic compounds from the bloodstream into urine. The most relevant drug transporter proteins involved in this process are stably and functionally expressed in our cell models.

Chaincraft

  • Enabling Technology
  • Other
  • Venture Challenge
ChainCraft offers a technological solution to the waste and agro-food industries to produce biochemicals

Chippoids

  • 2023
  • Enabling Technology
  • Venture Challenge
Chippoids is developing a unique multi-organ-on-chip system of the kidney and liver, for which the researchers use human organoids, and at the same time they are also developing a bloodvessel-on-a-chip.